Goodwin G. Jinesh

Cited by

	All	Since 2019
Citations	1238	722
h-index	20	14
i10-index	30	26

200

100

150

201120122013201420152016201720182019202020212022202320246 12 29 42 59 107 134 119 97 154 200 133 95 43

Public access

View all

17 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Ashish M. Kamat, MD, MBBS, FACSProfessor, MD Anderson Cancer CenterVerified email at mdanderson.org
Andrew BrohlMoffitt Cancer CenterVerified email at moffitt.org
Elsa FloresMoffitt Cancer CenterVerified email at moffitt.org
Ganiraju ManyamPrincipal BioAnalyst, Department of Bioinformatics & Computational Biology, The UT MD AndersonVerified email at mdanderson.org
Woonyoung ChoiJohns Hopkins School of medicine, Brady Urological InstituteVerified email at jhmi.edu
Santosh ChauhanSenior Principal Scientist; Wellcome-DBT & EMBO GIN Fellow; CSIR-CCMB & Institute of Life SciencesVerified email at ccmb.res.in
Jing WangProfessor of Bioinformatics, University of Texas M.D.Anderson Cancer CenterVerified email at mdanderson.org
David McConkeyProfessor of Urology and Cancer Biology, MD Anderson Cancer CenterVerified email at mdanderson.org
Deb SundiOhio State University - James Cancer HospitalVerified email at osumc.edu
Smruthi VijayaraghavanThe Janssen pharmaceutical companies of Johnson and JohnsonVerified email at its.jnj.com
Vaishnavi SambandamChampions Oncology Inc.,Verified email at championsoncology.com
Kavitha BalajiMedical Director, Immuno-Oncology, AstraZenecaVerified email at Astrazeneca.com
竹内　尚史 Takeuchi Hisashi東京医科大学 Tokyo Medical UniversityVerified email at tokyo-med.ac.jp
Stephen SafeProfessor of Toxicology, Texas A&M UniversityVerified email at cvm.tamu.edu
Marco NapoliH. Lee Moffitt Cancer CenterVerified email at Moffitt.org
Mai N. TranLecturer at International University HCM City - Vietnam National UniversityVerified email at mdanderson.org
Adam R. MetwalliProfessor & Chief of Urology, Howard University College of MedicineVerified email at huhosp.org
Sharada MokkapatiMD Anderson Cancer CenterVerified email at mdanderson.org
Gordon MillsOregon Health & Science UniversityVerified email at ohsu.edu
Damon ReedSenior Member, Moffitt Cancer CenterVerified email at moffitt.org

Goodwin G. Jinesh

Research Scientist-I, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA

Verified email at mdanderson.org - Homepage

Discovered blebbishield emergency program


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
ZKSCAN3 Is a Master Transcriptional Repressor of Autophagy S Chauhan, G Jinesh G, S Chauhan, G Manyam, J Wang, AM Kamat, ... Molecular Cell 50 (1), 16-28, 2013	279	2013
Molecular genetics and cellular events of K-Ras-driven tumorigenesis Jinesh GG, Sambandam V, Vijayaraghavan S, Balaji K, Mukherjee S. Oncogene 37, 839–846, 2018	94	2018
Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis Jinesh G., Choi, Shah, Lee, Willis, Kamat AM Cell Death & Differentiation 20 (3), 382-395, 2013	71	2013
Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL Jinesh G., Chunduru SK, AM. Kamat Journal of Leukocyte Biology 92 (1), 233-244, 2012	68	2012
Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis Jinesh GG, Manyam GC, Mmeje CO, Baggerly KA, Kamat AM. Scientific Reports 7 (doi:10.1038/s41598-017-08796-z), Article number: 9602, 2017	55	2017
Bladder cancer stem cells: biological and therapeutic perspectives Jinesh G., Willis DL, Kamat AM Current Stem Cell Research & Therapy 9 (2), 89-101, 2014	51	2014
Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers Jinesh GG, Flores ER., and Brohl AS. PLoS ONE 13 (10), e0206008, 2018	47	2018
Bladder Cancer Stem Cells M N Tran, G Jinesh, D J McConkey, A M Kamat Current Stem Cell Research & Therapy 5 (4), 387-395, 2010	46	2010
Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells AR Metwalli, S Khanbolooki, G Jinesh, D Sundi, JB Shah, M Shrader, ... Cancer biology & therapy 10 (9), 885-892, 2010	44	2010
Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks GG Jinesh, S Mokkapati, K Zhu, EE Morales Apoptosis 21 (11), 1203-1213, 2016	35	2016
Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis Jinesh, G.G., Brohl, A.S. Signal Transduction and Targeted Therapy 7, 296, 2022	33	2022
Blebbishield emergency program: an apoptotic route to cellular transformation Jinesh. GG, Kamat AM. Cell Death & Differentiation 23, 757-758, 2016	33	2016
Endocytosis and serpentine filopodia drive blebbishield-mediated resurrection of apoptotic cancer stem cells Jinesh. GG, Kamat AM. Cell Death Discovery 2, Article ID: 15069, 2016	31*	2016
Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination Jinesh G., AM. Kamat OncoImmunology 1 (7), 1161-1162, 2012	30	2012
Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis Jinesh. GG, JM. Molina, L. Huang, NM. Laing, GB. Mills, M. Bar-Eli, & AM. Kamat Cell Death Discovery 2, Article ID: 16003, 2016	29*	2016
The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss BA Setty, Jinesh GG, Pettersson P, Cheng C, Cen L, Yoder S, Teer J, Reed DR ... PLoS Genetics 16 (4), e1008642, 2020	25	2020
Novel PKC-ζ to p47phox interaction is necessary for transformation from blebbishields Jinesh. GG, Rikiya. T., Qiang. Z., Siddharth. G., Kamat. AM. Scientific Reports 6, Article ID: 23965, 2016	24	2016
Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo Jinesh, G., Lee EK., Tran J., Kamat, AM. Urologic Oncology: Seminars and Original Investigations, 2013	23	2013
Smac Mimetic with TNF-α Targets Pim-1 Isoforms and Reactive Oxygen Species Production to Abrogate Transformation from Blebbishields Jinesh. GG, Laing. NM, Kamat AM. Biochemical Journal 473 (1), 99-107, 2016	21	2016
A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin L Eugene, GG Jinesh, L Naomi, C Woonyoung, DJ McConkey, AM Kamat Cancer Biology & Therapy 14 (9), 2013	21	2013

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors